Notify me when RIVERVIEW GROUP LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences, Inc. | Common Stock, par value $0.001 per share | 1.3% | 3,583,100 | Millennium Management LLC | 17 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|